NYSE:JNJ

Johnson & Johnson Stock Forecast, Price & News

$177.51

+0.52 (+0.29%)

(As of 06/30/2022 12:00 AM ET)

Add

Compare

Today's Range: $175.03
▼
$178.29
50-Day Range: $168.19
▼
$186.01
52-Week Range: $155.72
▼
$186.69

Volume: 10.68 million shs
Average Volume: 7.87 million shs
Market Capitalization: $467.10 billion

P/E Ratio: 23.92
Dividend Yield: 2.55%
Price Target: $190.50

30 days | 90 days | 365 days | Advanced Chart

Receive JNJ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Johnson & Johnson and its competitors with MarketBeat's FREE daily newsletter.

JNJ Stock Forecast (MarketRank)

Overall MarketRank^™

3.05 out of 5 stars

Medical Sector

17th out of 1,433 stocks

Pharmaceutical Preparations Industry

3rd out of 684 stocks

2.3 Analyst's Opinion

Consensus Rating
Johnson & Johnson has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 6 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $190.50, Johnson & Johnson has a forecasted upside of 7.3% from its current price of $177.51.
Amount of Analyst Coverage
Johnson & Johnson has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

4.4 Community Rank

Outperform Votes
Johnson & Johnson has received 1,038 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Johnson & Johnson has received 537 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Johnson & Johnson has received 65.90% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Johnson & Johnson and other stocks. Vote “Outperform” if you believe JNJ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe JNJ will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Yield
Johnson & Johnson pays a meaningful dividend of 2.55%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Johnson & Johnson has been increasing its dividend for 61 years.
Dividend Coverage
The dividend payout ratio of Johnson & Johnson is 60.92%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Johnson & Johnson will have a dividend payout ratio of 42.16% next year. This indicates that Johnson & Johnson will be able to sustain or increase its dividend.

2.5 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Johnson & Johnson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,895,302.00 in company stock.
Percentage Held by Insiders
Only 0.35% of the stock of Johnson & Johnson is held by insiders.
Percentage Held by Institutions
68.78% of the stock of Johnson & Johnson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Johnson & Johnson are expected to grow by 4.79% in the coming year, from $10.23 to $10.72 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Johnson & Johnson is 23.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 34.53.
Price to Earnings Ratio vs. Sector
The P/E ratio of Johnson & Johnson is 23.92, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 34.76.
Price to Earnings Growth Ratio
Johnson & Johnson has a PEG Ratio of 3.61. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Johnson & Johnson has a P/B Ratio of 6.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

June 24, 2022 | marketbeat.com

Asian shares gain as investors shrug off downbeat data

Shares are higher in Asia despite data suggesting economies are slowing

June 24, 2022 | marketbeat.com

Asian shares gain, tracking Wall Street advance

Shares are higher in Asia, tracking gains on Wall Street, where the market is headed for its first weekly gain after three weeks of punishing losses

June 23, 2022 | marketbeat.com

Wall Street shakes off a midday stumble and ends higher

Stocks shook off a midday slump and ended higher, keeping major indexes on track for weekly gains

June 23, 2022 | marketbeat.com

US stocks waver as Fed chief addresses Congress again

Stocks gave up an early gain and turned mixed in afternoon trading on Wall Street Thursday as investors remain focused on inflation and rising interest rates

June 23, 2022 | marketbeat.com

US stocks rise as Fed chief addresses Congress again

Stocks rose in morning trading on Wall Street Thursday and added to gains for the week as investors remain focused on inflation and rising interest rates

June 21, 2022 | marketbeat.com

Snap, crackle, pop: Kellogg to split into 3 companies

Kellogg Co., the maker of Frosted Flakes, Rice Krispies and Eggo, will split into three companies focused on cereals, snacks and plant-based foods

June 7, 2022 | marketbeat.com

FDA advisers back Novavax COVID shots as 4th US option

A more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults

June 7, 2022 | marketbeat.com

FDA advisers back Novavax COVID-19 shots as new US option

A more traditional kind of COVID-19 vaccine has moved a step closer to the U.S. market

June 2, 2022 | marketbeat.com

Novavax hopes its COVID shot wins over FDA, vaccine holdouts

Americans may soon get a new COVID-19 vaccine option — a more traditional kind of shot known as a protein vaccine

June 30, 2022 | finance.yahoo.com

COVID SCIENCE-Pausing methotrexate improves booster response; first-trimester of pregnancy vaccination most beneficial

June 30, 2022 | stocknews.com

2 Low-Beta Mega Stocks That Could Outperform the Market

June 30, 2022 | forbes.com

Should You Buy Johnson & Johnson Stock At $177?

June 30, 2022 | finance.yahoo.com

Dow Jones Dives After Key Inflation Report

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceutical preparations
Sub-Industry: Pharmaceuticals
Sector: Medical
Current Symbol: NYSE:JNJ
CUSIP: 47816010
CIK: 200406
Web: www.jnj.com
Phone: (732) 524-0400
Fax: 732-214-0332
Employees: 141,700
Year Founded: 1886

Company Calendar

Last Earnings: 4/19/2022
Ex-Dividend for 6/7 Dividend: 5/23/2022
Dividend Payable: 6/07/2022
Today: 6/30/2022
Next Earnings (Confirmed): 7/19/2022
Fiscal Year End: 12/31/2022

Price Target and Rating

Average Stock Price Forecast: $190.50
High Stock Price Forecast: $205.00
Low Stock Price Forecast: $173.00
Forecasted Upside/Downside: +7.3%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.6
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $7.419990
Trailing P/E Ratio: 23.92
Forward P/E Ratio: 17.35
P/E Growth: 3.61
Net Income: $20.88 billion
Net Margins: 20.90%
Pretax Margin: 22.35%
Return on Equity: 36.59%
Return on Assets: 14.75%

Debt

Debt-to-Equity Ratio: 0.39
Current Ratio: 1.39
Quick Ratio: 1.14

Sales & Book Value

Annual Sales: $93.78 billion
Price / Sales: 4.98
Cash Flow: $12.42 per share
Price / Cash Flow: 14.29
Book Value: $28.12 per share
Price / Book: 6.31

Miscellaneous

Outstanding Shares: 2,631,402,000
Free Float: 2,622,192,000
Market Cap: $467.10 billion
Optionable: Optionable
Beta: 0.66

Social Links

Johnson & Johnson Frequently Asked Questions

Should I buy or sell Johnson & Johnson stock right now?: 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Johnson & Johnson in the last twelve months. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Johnson & Johnson stock.
View analyst ratings for Johnson & Johnson or view top-rated stocks.
What is Johnson & Johnson's stock price forecast for 2022?: 10 Wall Street research analysts have issued 12 month price objectives for Johnson & Johnson's shares. Their JNJ stock forecasts range from $173.00 to $205.00. On average, they expect Johnson & Johnson's stock price to reach $190.50 in the next year. This suggests a possible upside of 7.3% from the stock's current price.
View analysts' price targets for Johnson & Johnson or view top-rated stocks among Wall Street analysts.
How has Johnson & Johnson's stock performed in 2022?: Johnson & Johnson's stock was trading at $171.07 at the beginning of the year. Since then, JNJ stock has increased by 3.8% and is now trading at $177.51.
View the best growth stocks for 2022 here.
When is Johnson & Johnson's next earnings date?: Johnson & Johnson is scheduled to release its next quarterly earnings announcement on Tuesday, July 19th 2022.
View our earnings forecast for Johnson & Johnson.
How can I listen to Johnson & Johnson's earnings call?: Johnson & Johnson will be holding an earnings conference call on Tuesday, July 19th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Johnson & Johnson's earnings last quarter?: Johnson & Johnson (NYSE:JNJ) posted its quarterly earnings data on Tuesday, April, 19th. The company reported $2.67 earnings per share for the quarter, beating the consensus estimate of $2.60 by $0.07. The company earned $23.43 billion during the quarter, compared to the consensus estimate of $23.62 billion. Johnson & Johnson had a net margin of 20.90% and a trailing twelve-month return on equity of 36.59%. Johnson & Johnson's quarterly revenue was up 5.0% on a year-over-year basis. During the same period last year, the firm posted $2.59 EPS.
View Johnson & Johnson's earnings history.
How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?: Johnson & Johnson declared a quarterly dividend on Tuesday, April 19th. Investors of record on Tuesday, May 24th will be given a dividend of $1.13 per share on Tuesday, June 7th. This represents a $4.52 annualized dividend and a dividend yield of 2.55%. The ex-dividend date is Monday, May 23rd. This is an increase from Johnson & Johnson's previous quarterly dividend of $1.06.
View Johnson & Johnson's dividend history.
Is Johnson & Johnson a good dividend stock?: Johnson & Johnson(NYSE:JNJ) pays an annual dividend of $4.52 per share and currently has a dividend yield of 2.55%. Johnson & Johnson has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Johnson & Johnson is 60.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Johnson & Johnson will have a dividend payout ratio of 42.16% next year. This indicates that Johnson & Johnson will be able to sustain or increase its dividend.
View Johnson & Johnson's dividend history.
What guidance has Johnson & Johnson issued on next quarter's earnings?: Johnson & Johnson updated its FY 2022 earnings guidance on Tuesday, April, 26th. The company provided earnings per share (EPS) guidance of $10.150-$10.350 for the period, compared to the consensus estimate of $10.520. The company issued revenue guidance of $94.80 billion-$95.80 billion, compared to the consensus revenue estimate of $99.48 billion.
Who are Johnson & Johnson's key executives?: Johnson & Johnson's management team includes the following people:
Mr. Alex Gorsky, Exec. Chairman (Age 62, Pay $6.18M) (LinkedIn Profile)
Mr. Joaquin Duato, CEO & Director (Age 59, Pay $3.53M)
Mr. Joseph J. Wolk CPA, Exec. VP & CFO (Age 55, Pay $2.58M)
Ms. Jennifer L. Taubert, Exec. VP & Worldwide Chairman of Pharmaceuticals (Age 58, Pay $2.5M)
Mr. Robert J. Decker Jr., Controller & Chief Accounting Officer (Age 50) (LinkedIn Profile)
Mr. James Swanson, Exec. VP & Chief Information Officer
Ms. Jessica Moore, VP of Investor Relations
Mr. Michael H. Ullmann, Exec. VP & Gen. Counsel (Age 63)
Dr. Peter M. Fasolo Ph.D., Exec. VP & Chief HR Officer (Age 59)
Dr. Guy J. Lebeau M.D., Group Chairman of MD&D Bus. - EMEA

What is Alex Gorsky's approval rating as Johnson & Johnson's CEO?: 2,535 employees have rated Johnson & Johnson CEO Alex Gorsky on Glassdoor.com. Alex Gorsky has an approval rating of 94% among Johnson & Johnson's employees. This puts Alex Gorsky in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Who are some of Johnson & Johnson's key competitors?: Some companies that are related to Johnson & Johnson include Eli Lilly and (LLY), Pfizer (PFE), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT), Supernus Pharmaceuticals (SUPN), Nektar Therapeutics (NKTR) and Omeros (OMER).
View all of JNJ's competitors.
What other stocks do shareholders of Johnson & Johnson own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Johnson & Johnson investors own include AT&T (T), Pfizer (PFE), Verizon Communications (VZ), Walt Disney (DIS), NVIDIA (NVDA), Intel (INTC), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Procter & Gamble (PG) and AbbVie (ABBV).
What is Johnson & Johnson's stock symbol?: Johnson & Johnson trades on the New York Stock Exchange (NYSE) under the ticker symbol "JNJ."
How do I buy shares of Johnson & Johnson?: Shares of JNJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Johnson & Johnson's stock price today?: One share of JNJ stock can currently be purchased for approximately $177.51.
How much money does Johnson & Johnson make?: Johnson & Johnson (NYSE:JNJ) has a market capitalization of $467.10 billion and generates $93.78 billion in revenue each year. The company earns $20.88 billion in net income (profit) each year or $7.419990 on an earnings per share basis.
How many employees does Johnson & Johnson have?: Johnson & Johnson employs 141,700 workers across the globe.
Does Johnson & Johnson have any subsidiaries?: The following companies are subsidiares of Johnson & Johnson: 3Dintegrated ApS, ALZA Corporation, AMO (Hangzhou) Co. Ltd., AMO (Shanghai) Medical Devices Trading Co. Ltd., AMO ASIA LIMITED, AMO Australia Pty Limited, AMO Canada Company, AMO Denmark ApS, AMO Development LLC, AMO France, AMO Germany GmbH, AMO Groningen B.V., AMO International Holdings, AMO Ireland, AMO Ireland Finance Unlimited Company, AMO Italy SRL, AMO Japan K.K., AMO Manufacturing Spain S.L., AMO Manufacturing USA LLC, AMO Netherlands BV, AMO Nominee Holdings LLC, AMO Norway AS, AMO Puerto Rico Manufacturing Inc., AMO Sales and Service Inc., AMO Singapore Pte. Ltd., AMO Spain Holdings LLC, AMO Switzerland GmbH, AMO U.K. Holdings LLC, AMO US Holdings Inc., AMO USA LLC, AMO USA Sales Holdings Inc., AMO United Kingdom Ltd., AMO Uppsala AB, APSIS, AUB Holdings LLC, Abott Medical Optics, Acclarent Inc., Actelion Ltd, Actelion Manufacturing GmbH, Actelion Pharmaceuticals, Actelion Pharmaceuticals Australia Pty. Limited, Actelion Pharmaceuticals Korea Ltd., Actelion Pharmaceuticals Ltd, Actelion Pharmaceuticals Mexico S.A. De C.V., Actelion Pharmaceuticals Trading (Shanghai) Co. Ltd., Actelion Pharmaceuticals UK Limited, Actelion Pharmaceuticals US Inc., Actelion Registration Limited, Actelion Treasury Unlimited Company, Akros Medical Inc., Albany Street LLC, Alios BioPharma, Alza Land Management Inc., Animas Diabetes Care LLC, Animas LLC, Animas Technologies LLC, AorTx Inc., Aragon Pharmaceuticals, Aragon Pharmaceuticals Inc., Asia Pacific Holdings LLC, Atrionix Inc., Auris Health, Auris Health Inc., Backsvalan 2 Aktiebolag, Backsvalan 6 Handelsbolag, Beijing Dabao Cosmetics Co. Ltd., BeneVir BioPharm Inc., Berna Rhein B.V., BioMedical Enterprises Inc., Biosense Webster (Israel) Ltd., Biosense Webster Inc., C Consumer Products Denmark ApS, CNA Development GmbH, CSATS Inc., Calibra Medical LLC, Campus-Foyer Apotheke GmbH, Carlo Erba OTC S.r.l., Centocor Biologics LLC, Centocor Research & Development Inc., ChromaGenics B.V., Ci:Labo Customer Marketing Co. Ltd., Ci:z Holdings, Ci:z. Labo Co. Ltd., Cilag AG, Cilag GmbH International, Cilag Holding AG, Cilag Holding Treasury Unlimited Company, Cilag-Biotech S.L., CoTherix Inc., Codman & Shurtleff Inc., Coherex Medical Inc., ColBar LifeScience Ltd., Company Store.com Inc., Conor MedSystems, Cordis International Corporation, Cordis de Mexico S.A. de C.V., Corimmun GmbH, DR. CI:LABO COMPANY LIMITED, Darlain Trading S.A., DePuy France, DePuy Hellas SA, DePuy International Limited, DePuy Ireland Unlimited Company, DePuy Mexico S.A. de C.V., DePuy Mitek LLC, DePuy Orthopaedics Inc., DePuy Products Inc., DePuy Spine LLC, DePuy Synthes Gorgan Limited, DePuy Synthes Inc., DePuy Synthes Institute LLC, DePuy Synthes Leto SARL, DePuy Synthes Products Inc., DePuy Synthes Sales Inc., Debs-Vogue Corporation (Proprietary) Limited, Dr. Ci:Labo Co. Ltd., Dutch Holding LLC, ECL7 LLC, EES Holdings de Mexico S. de R.L. de C.V., EES S.A. de C.V., EIT Emerging Implant Technologies GmbH, Ethicon Biosurgery Ireland, Ethicon Endo-Surgery (Europe) GmbH, Ethicon Endo-Surgery Inc., Ethicon Endo-Surgery LLC, Ethicon Holding Sarl, Ethicon Inc., Ethicon Ireland Unlimited Company, Ethicon LLC, Ethicon PR Holdings Unlimited Company, Ethicon Sarl, Ethicon US LLC, Ethicon Women's Health & Urology Sarl, Ethnor (Proprietary) Limited, Ethnor Farmaceutica S.A., Ethnor Guatemala Sociedad Anomina, Ethnor del Istmo S.A., FMS Future Medical System SA, Finsbury (Development) Limited, Finsbury (Instruments) Limited, Finsbury Medical Limited, Finsbury Orthopaedics International Limited, Finsbury Orthopaedics Limited, GH Biotech Holdings Limited, GMED Healthcare BV, Global Investment Participation B.V., Guangzhou Bioseal Biotech Co. Ltd., Hansen Medical Deutschland GmbH, Hansen Medical Inc., Hansen Medical International Inc., Hansen Medical UK Limited, Healthcare Services (Shanghai) Ltd., I.D. Acquisition Corp., Innomedic Gesellschaft für innovative Medizintechnik und Informatik mbH, Innovalens B.V., Innovative Surgical Solutions LLC, J & J Company West Africa Limited, J&J Pension Trustees Limited, J-C Health Care Ltd., J.C. General Services BV, JJ Surgical Vision Spain S.L., JJC Acquisition Company B.V., JJHC LLC, JJSV Belgium BV, JJSV Manufacturing Malaysia SDN. BHD., JJSV Norden AB, JJSV Produtos Oticos Ltda., JNJ Global Business Services s.r.o., JNJ Holding EMEA B.V., JNJ International Investment LLC, JNJ Irish Investments ULC, JOM Pharmaceutical Services Inc., Janssen Alzheimer Immunotherapy (Holding) Limited, Janssen BioPharma Inc., Janssen Biologics (Ireland) Limited, Janssen Biologics B.V., Janssen Biotech Inc., Janssen Cilag C.A., Janssen Cilag Farmaceutica S.A., Janssen Cilag S.p.A., Janssen Cilag SPA, Janssen Development Finance Unlimited Company, Janssen Diagnostics LLC, Janssen Egypt LLC, Janssen Farmaceutica Portugal Lda, Janssen Global Services LLC, Janssen Group Holdings Limited, Janssen Holding GmbH, Janssen Inc., Janssen Irish Finance Company UC, Janssen Korea Ltd., Janssen Oncology Inc., Janssen Ortho LLC, Janssen Pharmaceutica (Proprietary) Limited, Janssen Pharmaceutica NV, Janssen Pharmaceutica S.A., Janssen Pharmaceutical, Janssen Pharmaceutical K.K., Janssen Pharmaceutical Sciences Unlimited Company, Janssen Pharmaceuticals Inc., Janssen Products LP, Janssen R&D Ireland, Janssen Research & Development LLC, Janssen Sciences Ireland Unlimited Company, Janssen Scientific Affairs LLC, Janssen Supply Group LLC, Janssen Vaccines & Prevention B.V., Janssen Vaccines Corp., Janssen de Mexico S. de R.L. de C.V., Janssen-Cilag, Janssen-Cilag (New Zealand) Limited, Janssen-Cilag A/S, Janssen-Cilag AG, Janssen-Cilag AS, Janssen-Cilag Aktiebolag, Janssen-Cilag B.V., Janssen-Cilag Farmaceutica Lda., Janssen-Cilag Farmaceutica Ltda., Janssen-Cilag GmbH, Janssen-Cilag International NV, Janssen-Cilag Kft., Janssen-Cilag Limited, Janssen-Cilag Manufacturing LLC, Janssen-Cilag NV, Janssen-Cilag OY, Janssen-Cilag Pharma GmbH, Janssen-Cilag Pharmaceutical S.A.C.I., Janssen-Cilag Polska Sp. z o.o., Janssen-Cilag Pty Ltd, Janssen-Cilag S.A., Janssen-Cilag S.A., Janssen-Cilag S.A. de C.V., Janssen-Cilag de Mexico S. de R.L. de C.V., Janssen-Cilag s.r.o., Janssen-Pharma S.L., Jevco Holding Inc., Johnson & Johnson, Johnson & Johnson (Angola) Limitada, Johnson & Johnson (China) Investment Ltd., Johnson & Johnson (Egypt) S.A.E., Johnson & Johnson (Hong Kong) Limited, Johnson & Johnson (Ireland) Limited, Johnson & Johnson (Jamaica) Limited, Johnson & Johnson (Kenya) Limited, Johnson & Johnson (Middle East) Inc., Johnson & Johnson (Mozambique) Limitada, Johnson & Johnson (Namibia) (Proprietary) Limited, Johnson & Johnson (New Zealand) Limited, Johnson & Johnson (Philippines) Inc., Johnson & Johnson (Private) Limited, Johnson & Johnson (Thailand) Ltd., Johnson & Johnson (Trinidad) Limited, Johnson & Johnson (Vietnam) Co. Ltd, Johnson & Johnson - Societa' Per Azioni, Johnson & Johnson AB, Johnson & Johnson AG, Johnson & Johnson Belgium Finance Company BV, Johnson & Johnson Bulgaria EOOD, Johnson & Johnson China Ltd., Johnson & Johnson Consumer (Hong Kong) Limited, Johnson & Johnson Consumer (Thailand) Limited, Johnson & Johnson Consumer B.V., Johnson & Johnson Consumer Holdings France, Johnson & Johnson Consumer Inc., Johnson & Johnson Consumer NV, Johnson & Johnson Consumer Saudi Arabia Limited, Johnson & Johnson Consumer Services EAME Ltd., Johnson & Johnson Del Paraguay S.A., Johnson & Johnson Dominicana S.A.S., Johnson & Johnson Enterprise Innovation Inc., Johnson & Johnson European Treasury Company, Johnson & Johnson Finance Corporation, Johnson & Johnson Finance Limited, Johnson & Johnson Financial Services GmbH, Johnson & Johnson Foundation Scotland (NON-PROFIT), Johnson & Johnson Gateway LLC, Johnson & Johnson Gesellschaft m.b.H., Johnson & Johnson GmbH, Johnson & Johnson Guatemala S.A., Johnson & Johnson Health Care Systems Inc., Johnson & Johnson Health and Wellness Solutions Inc., Johnson & Johnson Hellas Commercial and Industrial S.A., Johnson & Johnson Hellas Consumer Products Commercial Societe Anonyme, Johnson & Johnson Hemisferica S.A., Johnson & Johnson Holding GmbH, Johnson & Johnson Holdings K.K., Johnson & Johnson Inc., Johnson & Johnson Industrial Ltda., Johnson & Johnson Innovation - JJDC Inc., Johnson & Johnson Innovation LLC, Johnson & Johnson Innovation Limited, Johnson & Johnson International, Johnson & Johnson International (Singapore) Pte. Ltd., Johnson & Johnson International Financial Services Company, Johnson & Johnson Japan Inc., Johnson & Johnson K.K., Johnson & Johnson Kft., Johnson & Johnson Korea Ltd., Johnson & Johnson Korea Selling & Distribution LLC, Johnson & Johnson LLC, Johnson & Johnson Limitada, Johnson & Johnson Limited, Johnson & Johnson Luxembourg Finance Company Sarl, Johnson & Johnson Management Limited, Johnson & Johnson Medical (China) Ltd., Johnson & Johnson Medical (Proprietary) Ltd, Johnson & Johnson Medical (Shanghai) Ltd., Johnson & Johnson Medical (Suzhou) Ltd., Johnson & Johnson Medical B.V., Johnson & Johnson Medical Devices & Diagnostics Group - Latin America L.L.C., Johnson & Johnson Medical GmbH, Johnson & Johnson Medical Korea Ltd., Johnson & Johnson Medical Limited, Johnson & Johnson Medical Mexico S.A. de C.V., Johnson & Johnson Medical NV, Johnson & Johnson Medical Products GmbH, Johnson & Johnson Medical Pty Ltd, Johnson & Johnson Medical S.A., Johnson & Johnson Medical S.C.S., Johnson & Johnson Medical S.p.A., Johnson & Johnson Medical SAS, Johnson & Johnson Medical Saudi Arabia Limited, Johnson & Johnson Medical Servicios Profesionales S. de R.L. de C.V., Johnson & Johnson Medical Taiwan Ltd., Johnson & Johnson Medikal Sanayi ve Ticaret Limited Sirketi, Johnson & Johnson Middle East FZ-LLC, Johnson & Johnson Morocco Societe Anonyme, Johnson & Johnson Nordic AB, Johnson & Johnson Pacific Pty Limited, Johnson & Johnson Pakistan (Private) Limited, Johnson & Johnson Panama S.A., Johnson & Johnson Personal Care (Chile) S.A., Johnson & Johnson Poland Sp. z o.o., Johnson & Johnson Private Limited, Johnson & Johnson Pte. Ltd., Johnson & Johnson Pty. Limited, Johnson & Johnson Research Pty Ltd, Johnson & Johnson Romania S.R.L., Johnson & Johnson S.A., Johnson & Johnson S.A. de C.V., Johnson & Johnson S.E. Inc., Johnson & Johnson S.E. d.o.o., Johnson & Johnson SDN. BHD., Johnson & Johnson Sante Beaute France, Johnson & Johnson Services Inc., Johnson & Johnson Servicios Corporativos S. de R.L. de C.V., Johnson & Johnson Surgical Vision Inc., Johnson & Johnson Surgical Vision India Private Limited, Johnson & Johnson Taiwan Ltd., Johnson & Johnson UK Treasury Company Limited, Johnson & Johnson Ukraine LLC, Johnson & Johnson Urban Renewal Associates, Johnson & Johnson Vision Care (Shanghai) Ltd., Johnson & Johnson Vision Care Inc., Johnson & Johnson Vision Care Ireland Unlimited Company, Johnson & Johnson d.o.o., Johnson & Johnson de Argentina S.A.C. e. I., Johnson & Johnson de Chile Limitada, Johnson & Johnson de Chile S.A., Johnson & Johnson de Colombia S.A., Johnson & Johnson de Costa Rica S.A., Johnson & Johnson de Mexico S.A. de C.V., Johnson & Johnson de Uruguay S.A., Johnson & Johnson de Venezuela S.A., Johnson & Johnson del Ecuador S.A., Johnson & Johnson del Peru S.A., Johnson & Johnson do Brasil Industria E Comercio de Produtos Para Saude Ltda., Johnson & Johnson for Export and Import LLC, Johnson & Johnson s.r.o., Johnson and Johnson (Proprietary) Limited, Johnson and Johnson Sihhi Malzeme Sanayi Ve Ticaret Limited Sirketi, La Concha Land Investment Corporation, Latam International Investment Company Unlimited Company, LifeScan, MDS Co. Ltd., McNEIL MMP LLC, McNeil AB, McNeil Consumer Pharmaceuticals Co., McNeil Denmark ApS, McNeil Healthcare (Ireland) Limited, McNeil Healthcare (UK) Limited, McNeil Healthcare LLC, McNeil Iberica S.L.U., McNeil LA LLC, McNeil Nutritionals LLC, McNeil Panama LLC, McNeil Products Limited, McNeil Sweden AB, Medical Device Business Services Inc., Medical Devices & Diagnostics Global Services LLC, Medical Devices International LLC, Medical Industrial do Brasil Ltda., Medos International Sarl, Medos Sarl, MegaDyne Medical Products Inc., Menlo Care De Mexico S.A. de C.V., Mentor B.V., Mentor Deutschland GmbH, Mentor Medical Systems B.V., Mentor Partnership Holding Company I LLC, Mentor Texas GP LLC, Mentor Texas L.P., Mentor Worldwide LLC, Micrus Endovascular LLC, Middlesex Assurance Company Limited, Momenta Ireland Limited, Momenta Pharmaceuticals, Momenta Pharmaceuticals Inc., NeoStrata Company Inc., NeoStrata Company Inc., NeoStrata UG (haftungsbeschränkt), Netherlands Holding Company, NeuWave Medical Inc., Neuravi Inc., Neuravi Limited, Novira Therapeutics, Novira Therapeutics LLC, NuVera Medical Inc., OBTECH Medical Sarl, OGX Beauty AU Pty Ltd, OGX Beauty Limited, OMJ Holding GmbH, OMJ Ireland Unlimited Company, OMJ Pharmaceuticals Inc., Obtech Medical Mexico S.A. de C.V., Omrix Biopharmaceuticals Inc., Omrix Biopharmaceuticals Ltd., Omrix Biopharmaceuticals NV, Ortho Biologics LLC, Ortho Biotech Holding LLC, Ortho-McNeil Pharmaceutical LLC, Orthotaxy, Orthotaxy, PMC Holdings G.K., PT Integrated Healthcare Indonesia, PT. Johnson & Johnson Indonesia, Patriot Pharmaceuticals LLC, Peninsula Pharmaceuticals LLC, Penta Pty. Limited, Percivia LLC, Perouse Plastie, Pharmadirect Ltd., Pharmedica Laboratories (Proprietary) Limited, Princeton Laboratories Inc., Productos de Cuidado Personal y de La Salud de Bolivia S.R.L., Proleader S.A., Pulsar Vascular Inc., Regency Urban Renewal Associates, RespiVert Ltd., RoC International, Rutan Realty LLC, SYNTHES Medical Immobilien GmbH, Scios LLC, Sedona Enterprise Co. Ltd., Sedona Singapore International Pte. Ltd., Sedona Thai International Co. Ltd., Serhum S.A. de C.V., Shanghai Elsker For Mother & Baby Co. Ltd, Shanghai Johnson & Johnson Ltd., Shanghai Johnson & Johnson Pharmaceuticals Ltd., Sightbox LLC, Sodiac ESV, Spectrum Vision Limited Liability Company, Spectrum Vision Limited Liability Partnership, Spine Solutions GmbH, SterilMed, SterilMed Inc., Surgical Process Institute Deutschland GmbH, Synthes Costa Rica S.C.R. Limitada, Synthes GmbH, Synthes Holding AG, Synthes Holding Limited, Synthes Inc., Synthes Medical Surgical Equipment & Instruments Trading LLC, Synthes Produktions GmbH, Synthes Proprietary Limited, Synthes S.M.P. S. de R.L. de C.V., Synthes Tuttlingen GmbH, Synthes USA LLC, Synthes USA Products LLC, TARIS Biomedical, TARIS Biomedical LLC, TearScience Inc., The Anspach Effort LLC, The Vision Care Institute LLC, Tibotec LLC, Torax Medical Inc., TriStrata Incorporated, UAB "Johnson & Johnson", Vania Expansion, Verb Surgical, Verb Surgical Inc., Vision Care Finance Unlimited Company, Vogue International, Vogue International LLC, Vogue International Trading Inc., WH4110 Development Company L.L.C., XO1, XO1 Limited, Xian Janssen Pharmaceutical Ltd., Zarbee's Inc., and Zarbee's Naturals.
Read More
When was Johnson & Johnson founded?: Johnson & Johnson was founded in 1886.
How can I contact Johnson & Johnson?: Johnson & Johnson's mailing address is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. The official website for Johnson & Johnson is www.jnj.com. The company can be reached via phone at (732) 524-0400 or via fax at 732-214-0332.

This page (NYSE:JNJ) was last updated on 7/1/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Johnson & Johnson Stock Forecast, Price & News

Receive JNJ Stock News and Ratings via Email

JNJ Stock Forecast (MarketRank)

Overall MarketRank™

2.3 Analyst's Opinion

4.4 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

4.2 Dividend Strength

2.5 Company Ownership

1.9 Earnings and Valuation

About Johnson & Johnson (NYSE:JNJ)

JNJ Stock News Headlines

Industry, Sector and Symbol

Company Calendar

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Johnson & Johnson Frequently Asked Questions

Should I buy or sell Johnson & Johnson stock right now?

What is Johnson & Johnson's stock price forecast for 2022?

How has Johnson & Johnson's stock performed in 2022?

When is Johnson & Johnson's next earnings date?

How can I listen to Johnson & Johnson's earnings call?

How were Johnson & Johnson's earnings last quarter?

How often does Johnson & Johnson pay dividends? What is the dividend yield for Johnson & Johnson?

Is Johnson & Johnson a good dividend stock?

What guidance has Johnson & Johnson issued on next quarter's earnings?

Who are Johnson & Johnson's key executives?

What is Alex Gorsky's approval rating as Johnson & Johnson's CEO?

Who are some of Johnson & Johnson's key competitors?

What other stocks do shareholders of Johnson & Johnson own?

What is Johnson & Johnson's stock symbol?

How do I buy shares of Johnson & Johnson?

What is Johnson & Johnson's stock price today?

How much money does Johnson & Johnson make?

How many employees does Johnson & Johnson have?

Does Johnson & Johnson have any subsidiaries?

When was Johnson & Johnson founded?

How can I contact Johnson & Johnson?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™